CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CellaVision AB
Other Current Liabilities Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Other Current Liabilities
kr57.2m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
8%
Elekta AB (publ)
STO:EKTA B
Other Current Liabilities
kr8.4B
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Other Current Liabilities
kr256.3m
CAGR 3-Years
61%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Other Current Liabilities
kr4.9B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Other Current Liabilities
kr534m
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Other Current Liabilities
kr183.8m
CAGR 3-Years
84%
CAGR 5-Years
43%
CAGR 10-Years
37%

See Also

What is CellaVision AB's Other Current Liabilities?
Other Current Liabilities
57.2m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Other Current Liabilities amounts to 57.2m SEK.

What is CellaVision AB's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
8%

Over the last year, the Other Current Liabilities growth was 20%. The average annual Other Current Liabilities growth rates for CellaVision AB have been 8% over the past three years , 4% over the past five years , and 8% over the past ten years .

Back to Top